CONMED Corp (CNMD)

↓ Download CSV

CIK 0000816956 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CONMED Corp reported revenue of $1.37B, up 5.2% from the prior year. The company was profitable, with a net margin of 3.4% and a gross margin of 54.6%. It held $2.33B in total assets against $1.29B in total liabilities.

Key ratios (FY2025)

54.6%
Gross margin
7.5%
Operating margin
3.4%
Net margin
4.6%
Return on equity
+5.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.37B$1.31B$1.24B$1.05B$1.01B$862.46M$955.10M$859.63M$796.39M$763.52M
Cost of Revenue$624.25M$573.98M$568.50M$474.23M$442.60M$402.16M$430.38M$390.52M$365.35M$355.19M
Gross Profit$750.48M$733.03M$676.25M$571.25M$568.04M$460.30M$524.72M$469.11M$431.04M$408.33M
Operating Income$102.62M$200.33M$120.60M$70.05M$109.72M$46.01M$79.11M$71.31M$46.94M$37.68M
Net Income$47.05M$132.42M$64.46M-$80.58M$62.54M$9.52M$28.62M$40.85M$55.49M$14.66M
EPS (Diluted)$1.51$4.25$2.04$-2.68$1.94$0.32$0.97$1.41$1.97$0.52
Total Assets$2.33B$2.31B$2.30B$2.30B$1.77B$1.75B$1.78B$1.37B$1.36B$1.33B
Total Liabilities$1.29B$1.34B$1.47B$1.55B$980.58M$1.04B$1.06B$706.87M$726.53M$748.41M
Shareholders' Equity$1.03B$962.68M$834.22M$745.54M$785.43M$709.04M$710.47M$662.27M$631.43M$580.58M
Cash & Equivalents$25.86M$17.51M$32.62M$27.43M
Operating Cash Flow$170.69M$166.97M$125.35M$33.37M$111.77M$64.53M$95.13M$74.70M$65.57M$39.88M
Capital Expenditures$19.81M$13.08M$19.03M$21.79M$14.87M$13.01M$20.07M$16.51M$12.84M$14.75M
Shares Outstanding31.15M31.15M31.55M30.04M32.22M29.46M29.50M28.89M28.17M27.96M
Dividends Per Share$0.60$0.80$0.80$0.80$0.80$0.80$0.80$0.80$0.80$0.80